The genetic duet of BRAF V600E and TERT promoter mutations predicts the poor curative effect of radioiodine therapy in papillary thyroid cancer.
Jingjia CaoXiaolu ZhuYaru SunXiao LiCanhua YunWei ZhangPublished in: European journal of nuclear medicine and molecular imaging (2022)
ClinicalTrials.gov Identifier: ChiCTR1800018760.